Home › Steatotic Liver Disease › Florida › Orlando
Steatotic Liver Disease clinical trials in Orlando, FL
9 studies for Steatotic Liver Disease are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Winter Park · 5 mi away
- 89bio Clinical Study Site, Ocoee · 10 mi away
- 89bio Clinical Study Site, Clermont · 24 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Winter Park · 5 mi away
- 89bio Clinical Study Site, Maitland · 6 mi away
- 89bio Clinical Study Site, Ocoee · 10 mi away
- and 1 more
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RecruitingPhase 2
- Charter Research LLC - Orlando, Orlando
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Charter Research - Orlando, Orlando
- Headlands Research Orlando, Orlando
- K2 Medical Research WINTER GARDEN, Clermont · 24 mi away
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Orlando
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Maitland · 6 mi away
- GSK Investigational Site, Kissimmee · 16 mi away
- GSK Investigational Site, Clermont · 24 mi away
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
RecruitingHealthy volunteers welcome
- AdventHealth Translational Research Institute, Orlando
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Maitland · 6 mi away
- GSK Investigational Site, Kissimmee · 16 mi away
- GSK Investigational Site, Clermont · 24 mi away
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
RecruitingObservational studyHealthy volunteers welcome
- AdventHealth Translational Research Institute, Orlando
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Hialeah, FL9 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity32 studies
- Metastatic Cancer29 studies
- Overweight27 studies
- Alzheimer's Disease25 studies
- Type 2 Diabetes25 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Colorectal Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.